• The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: Results from a randomized controlled trial (SURF trial)

    Thumbnail Image

    Files

    1-s2.0-S0016510716308148-main.pdf (558.44 KB)

    Date

    2016

    Authors

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Phoa K.N, Rosmolen W.D, Weusten B.L.A.M, Bisschops R, Schoon E.J, Das S, Ragunath K, Fullarton G, DiPietro M, Ravi N, Tijssen J.G.P, Dijkgraaf M.G.W, Bergman J.J.G.H.M, The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: Results from a randomized controlled trial (SURF trial), Gastrointestinal Endoscopy, 2016, 1--

    Abstract

    Background and Aims The Surveillance versus Radiofrequency Ablation (SURF) trial randomized 136 patients with Barrett's esophagus (BE) containing low-grade dysplasia (LGD), to receive radiofrequency ablation (ablation, n = 68) or endoscopic surveillance (control, n = 68). Ablation reduced the risk of neoplastic progression to high-grade dysplasia and esophageal adenocarcinoma (EAC) by 25% over 3 years (1.5% for ablation vs 26.5% for control). We performed a cost-effectiveness analysis from a provider perspective alongside this trial.

    Description

    IN_PRESS

    URI

    http://hdl.handle.net/2262/79445

    Collections

    Surgery (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Surveillance versus Radiofrequency Ablation (SURF) trial
    Author's Homepage: http://people.tcd.ie/ravin

    Author: RAVI, NARAYANASAMY

    Type of material: Journal Article